Mercialys


Not that bad indeed !

17/10/19 -"The still robust indexation, well above global inflation, brought half of the organic growth in Q3 19, as it did in H1 19. In Q4 19 and Q1 20, Mercialys and other similar companies will benefit from ..."

Pages
65
Language
English
Published on
17/10/19
You may also be interested by these reports :
27/03/24
Extension of debt maturities reached – Disposals have to remain on the agenda to lower the leverage

27/03/24
FFO decline by 8% in FY23 and by 7-16% in FY24E – 11% portfolio write-down and dividend suspension in-line with our estimates

25/03/24
Good execution – But when do investors finally appreciate it?

25/03/24
Solid, but we miss a short-term catalyst and momentum

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO